{"id":785701,"date":"2023-09-22T09:31:41","date_gmt":"2023-09-22T13:31:41","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\/"},"modified":"2023-09-22T09:31:41","modified_gmt":"2023-09-22T13:31:41","slug":"aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\/","title":{"rendered":"AIM ImmunoTech Selected to Present at the 3rd Annual Marie Sklodowska-Curie Symposium on Cancer Research and Care"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">OCALA, Fla., Sept.  22, 2023  (GLOBE NEWSWIRE) &#8212; <strong>AIM ImmunoTech Inc. (NYSE American: AIM) <\/strong>(\u201cAIM\u201d or the \u201cCompany\u201d) today announced Chris McAleer, Ph.D., Scientific Officer of AIM will present at the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tbUVdrH5Vjv6H57wFtnAZQRL7eJRi3LEVc-V5wE7zBj3P4rAbODkgDleD7K5ykR5bOrpW45UP-Sqe2v1iummcl_mH4eYhvc93xf9XCXAQpIhR-nzRWRxH7yj6RKMRZ5FWArjsYys06KH6QMcBR83U_fs_CytRriH7BS2yL_U0fZ5WAe9BOioht4_kiLtT2VM\" rel=\"nofollow noopener\" target=\"_blank\">3<sup>rd<\/sup> Annual Marie Sklodowska-Curie Symposium on Cancer Research and Care<\/a> being held at the Roswell Park Comprehensive Cancer Center in Buffalo, N.Y., September 20-22, 2023. In addition to the presentation, the Company is proud to announce its sponsorship of the event.<\/p>\n<p align=\"justify\">Details for the presentation are as follows:<\/p>\n<p align=\"justify\">\n        <strong>Title: <\/strong><br \/>\n        <em>Rintatolimod (Ampligen<sup>\u00ae<\/sup>): Overview of Ampligen\u2019s Clinical Progress in Oncology<\/em><br \/>\n        <br \/>\n        <strong>Presenter:<\/strong> Christopher McAleer, Ph.D.<br \/><strong>Session: <\/strong>Session 7: Team Science: National and International Collaborations with NGOs, Academia, Pharma, &amp; Biotech<br \/><strong>Date: <\/strong>Friday, September 22, 2023<\/p>\n<p align=\"justify\">For more information about the conference, visit: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kkLXsSF0JGbuD_I1C7WOQ3pmV_eXYPe0oR6cE9OAl-PPxR0qZoPcnAZd5dEif5ysxhj1rX_15XNvQ2SJd-We1EIbZm9_U0Vsr1rxBR9binBYCSioHGrgQ2-QpdLNx1JEpjFFEOwXYEZPSerUmvx_lQ==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.roswellpark.org\/msc-symposium<\/a>.<\/p>\n<p align=\"justify\">The presentation will be available on the AIM <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UviDYkwrYgFFINrmcxQNLoSusSk68Ft9zuBVoZq4NFJKsygBJ6fChy5zayGQpqvlE-5e9A7aoks-W_yeiIkVGdvNZriSuSC-jZIMFmWHO78=\" rel=\"nofollow noopener\" target=\"_blank\">website<\/a> once presented at the conference.<\/p>\n<p align=\"justify\">\n        <strong>About AIM ImmunoTech Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company\u2019s lead product is a first-in-class investigational drug called Ampligen<sup>\u00ae<\/sup> (rintatolimod), a dsRNA and highly selective TLR3 agonist immuno-modulator with broad spectrum activity in clinical trials for globally important cancers, viral diseases and disorders of the immune system.<\/p>\n<p align=\"justify\">For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LKAYalkSBGb4u3TISaMTmAyQxCHjqVX5Rp-vPgwQLleYxFZMqV36cSISOFWR4ao6zKxkFO2L90ef-VhztABKmA==\" rel=\"nofollow noopener\" target=\"_blank\">aimimmuno.com<\/a>\u00a0and connect with the Company on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6KYc5SQ4xe_0MoaS-B-e9ZdKQ_6V7mTUhmjlQf9Vg2Ok4dQoH5mwBC0dsJyP7HPdQy4qNZ7VoA3tWKyFM-6_NA==\" rel=\"nofollow noopener\" target=\"_blank\">Twitter<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=U3bZrJ4QTADFYS9Avl16Zq-14xq0F8NisFNyRrhOLoduINr4BglcZrM_VftzhXmLlBzuPR00BjW50-e4_9BoSr_th-nTw0XsR3lBDcRt_5xr-5Dth9HwaugpSI9wAvYa\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a>, and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MVebbJU7BxdPL_aj4zhyOIUMAht_3lrudxJiVZgFzqqHo3f-RtwRnPR7feIdT8LyurCR_S23z4HHLYa3tPLgxJJmdbH1NTygZ-AZ2LPgmpg=\" rel=\"nofollow noopener\" target=\"_blank\">Facebook<\/a>.<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyNjQ0NyM1ODI2NjE3IzIwMjMxNjQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MWIwYzE3ZDQtYWUyYy00NjQ2LTkxZTYtYjRhYjY5NDVjZjNlLTEwMzQ3MzU=\/tiny\/AIM-ImmunoTech-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Investor Contact:\r\n\r\nJTC Team, LLC\r\nJenene Thomas\r\n(833) 475-8247\r\nAIM@jtcir.com<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>OCALA, Fla., Sept. 22, 2023 (GLOBE NEWSWIRE) &#8212; AIM ImmunoTech Inc. (NYSE American: AIM) (\u201cAIM\u201d or the \u201cCompany\u201d) today announced Chris McAleer, Ph.D., Scientific Officer of AIM will present at the 3rd Annual Marie Sklodowska-Curie Symposium on Cancer Research and Care being held at the Roswell Park Comprehensive Cancer Center in Buffalo, N.Y., September 20-22, 2023. In addition to the presentation, the Company is proud to announce its sponsorship of the event. Details for the presentation are as follows: Title: Rintatolimod (Ampligen\u00ae): Overview of Ampligen\u2019s Clinical Progress in Oncology Presenter: Christopher McAleer, Ph.D.Session: Session 7: Team Science: National and International Collaborations with NGOs, Academia, Pharma, &amp; BiotechDate: Friday, September 22, 2023 For more information about the conference, visit: https:\/\/www.roswellpark.org\/msc-symposium. The &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;AIM ImmunoTech Selected to Present at the 3rd Annual Marie Sklodowska-Curie Symposium on Cancer Research and Care&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-785701","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AIM ImmunoTech Selected to Present at the 3rd Annual Marie Sklodowska-Curie Symposium on Cancer Research and Care - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AIM ImmunoTech Selected to Present at the 3rd Annual Marie Sklodowska-Curie Symposium on Cancer Research and Care - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"OCALA, Fla., Sept. 22, 2023 (GLOBE NEWSWIRE) &#8212; AIM ImmunoTech Inc. (NYSE American: AIM) (\u201cAIM\u201d or the \u201cCompany\u201d) today announced Chris McAleer, Ph.D., Scientific Officer of AIM will present at the 3rd Annual Marie Sklodowska-Curie Symposium on Cancer Research and Care being held at the Roswell Park Comprehensive Cancer Center in Buffalo, N.Y., September 20-22, 2023. In addition to the presentation, the Company is proud to announce its sponsorship of the event. Details for the presentation are as follows: Title: Rintatolimod (Ampligen\u00ae): Overview of Ampligen\u2019s Clinical Progress in Oncology Presenter: Christopher McAleer, Ph.D.Session: Session 7: Team Science: National and International Collaborations with NGOs, Academia, Pharma, &amp; BiotechDate: Friday, September 22, 2023 For more information about the conference, visit: https:\/\/www.roswellpark.org\/msc-symposium. The &hellip; Continue reading &quot;AIM ImmunoTech Selected to Present at the 3rd Annual Marie Sklodowska-Curie Symposium on Cancer Research and Care&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-22T13:31:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyNjQ0NyM1ODI2NjE3IzIwMjMxNjQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"AIM ImmunoTech Selected to Present at the 3rd Annual Marie Sklodowska-Curie Symposium on Cancer Research and Care\",\"datePublished\":\"2023-09-22T13:31:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\\\/\"},\"wordCount\":243,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyNjQ0NyM1ODI2NjE3IzIwMjMxNjQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\\\/\",\"name\":\"AIM ImmunoTech Selected to Present at the 3rd Annual Marie Sklodowska-Curie Symposium on Cancer Research and Care - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyNjQ0NyM1ODI2NjE3IzIwMjMxNjQ=\",\"datePublished\":\"2023-09-22T13:31:41+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyNjQ0NyM1ODI2NjE3IzIwMjMxNjQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyNjQ0NyM1ODI2NjE3IzIwMjMxNjQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AIM ImmunoTech Selected to Present at the 3rd Annual Marie Sklodowska-Curie Symposium on Cancer Research and Care\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AIM ImmunoTech Selected to Present at the 3rd Annual Marie Sklodowska-Curie Symposium on Cancer Research and Care - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\/","og_locale":"en_US","og_type":"article","og_title":"AIM ImmunoTech Selected to Present at the 3rd Annual Marie Sklodowska-Curie Symposium on Cancer Research and Care - Market Newsdesk","og_description":"OCALA, Fla., Sept. 22, 2023 (GLOBE NEWSWIRE) &#8212; AIM ImmunoTech Inc. (NYSE American: AIM) (\u201cAIM\u201d or the \u201cCompany\u201d) today announced Chris McAleer, Ph.D., Scientific Officer of AIM will present at the 3rd Annual Marie Sklodowska-Curie Symposium on Cancer Research and Care being held at the Roswell Park Comprehensive Cancer Center in Buffalo, N.Y., September 20-22, 2023. In addition to the presentation, the Company is proud to announce its sponsorship of the event. Details for the presentation are as follows: Title: Rintatolimod (Ampligen\u00ae): Overview of Ampligen\u2019s Clinical Progress in Oncology Presenter: Christopher McAleer, Ph.D.Session: Session 7: Team Science: National and International Collaborations with NGOs, Academia, Pharma, &amp; BiotechDate: Friday, September 22, 2023 For more information about the conference, visit: https:\/\/www.roswellpark.org\/msc-symposium. The &hellip; Continue reading \"AIM ImmunoTech Selected to Present at the 3rd Annual Marie Sklodowska-Curie Symposium on Cancer Research and Care\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\/","og_site_name":"Market Newsdesk","article_published_time":"2023-09-22T13:31:41+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyNjQ0NyM1ODI2NjE3IzIwMjMxNjQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"AIM ImmunoTech Selected to Present at the 3rd Annual Marie Sklodowska-Curie Symposium on Cancer Research and Care","datePublished":"2023-09-22T13:31:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\/"},"wordCount":243,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyNjQ0NyM1ODI2NjE3IzIwMjMxNjQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\/","name":"AIM ImmunoTech Selected to Present at the 3rd Annual Marie Sklodowska-Curie Symposium on Cancer Research and Care - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyNjQ0NyM1ODI2NjE3IzIwMjMxNjQ=","datePublished":"2023-09-22T13:31:41+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyNjQ0NyM1ODI2NjE3IzIwMjMxNjQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyNjQ0NyM1ODI2NjE3IzIwMjMxNjQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aim-immunotech-selected-to-present-at-the-3rd-annual-marie-sklodowska-curie-symposium-on-cancer-research-and-care\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"AIM ImmunoTech Selected to Present at the 3rd Annual Marie Sklodowska-Curie Symposium on Cancer Research and Care"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/785701","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=785701"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/785701\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=785701"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=785701"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=785701"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}